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Abstract
Low cerebral blood flow (CBF) states have been demonstrated in children early after traumatic brain injury (TBI), and have
been correlated with poorer outcomes. Cerebral perfusion pressure (CPP) support following severe TBI is commonly
implemented to correct cerebral hypoperfusion, but the efficacy of various vasopressors has not been determined. Sixteen
4-week-old female swine underwent nonimpact inertial brain injury in the sagittal plane. Intraparenchymal monitors were
placed to measure intracranial pressure (ICP), CBF, brain tissue oxygen tension (PbtO2), and cerebral microdialysis 30min to
6 h post-injury. One hour after injury, animals were randomized to receive either phenylephrine (PE) or norepinephrine (NE)
infusions titrated to a CPP > 70mm Hg for 5 h. Animals were euthanized 6 h post-TBI, and brains were fixed and stained to
assess regions of cell and axonal injury. After initiation of CPP augmentation with NE or PE infusions, there were no
differences in ICP between the groups or over time. Animals receiving NE had higher PbtO2 than those receiving PE
(29.6– 10.2 vs. 19.6– 6.4 torr at 6 h post-injury, p< 0.05). CBF increased similarly in both the NE and PE groups. CPP
support with PE resulted in a greater reduction in metabolic crisis than with NE (lactate/pyruvate ratio 16.7– 2.4 vs.
42.7– 10.2 at 6 h post-injury, p< 0.05). Augmentation of CPP to 70mm Hg with PE resulted in significantly smaller cell
injury volumes at 6 h post-injury than CPP support with NE (0.4% vs. 1.4%, p< 0.05). Despite similar increases in CBF, CPP
support with NE resulted in greater brain tissue oxygenation and hypoxic-ischemic injury than CPP support with PE. Future
clinical studies comparing the effectiveness of various vasopressors for CPP support are warranted.
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Introduction
Low cerebral blood flow (CBF) states have been demon-strated in children early after traumatic brain injury (TBI) and
have been correlated with poorer outcomes.1,2 Cerebral perfusion
pressure (CPP) support following severe TBI is commonly im-
plemented to correct cerebral hypoperfusion and prevent or mini-
mize secondary brain injury.3 The most recent Brain Trauma
Foundation guidelines recommended a minimum CPP threshold of
40mm Hg with no recommendations on how to achieve this
threshold or on what is an optimal upper limit for age- specific CPP
thresholds.4
Vasopressors are typically employed as a treatment strategy to
increase CPP after TBI by raising mean arterial pressure (MAP).
Currently, there are no recommendations for the choice of vaso-
pressor, and there are only limited studies comparing the effec-
tiveness of commonly used agents for CPP support in TBI.5–9 Adult
studies comparing vasopressor efficacy have been limited to single
center retrospective and small prospective studies.6–9 None of these
studies observed significant differences in CBF velocity, metabo-
lism, or oxygenation. In a single center retrospective study of pe-
diatric patients with severe TBI, phenylephrine (PE) followed by
norepinephrine (NE) were found to be the most common vaso-
pressors utilized, and post-hoc analysis did not reveal any signifi-
cant differences in cerebral hemodynamic responses between the
two vasopressors.5
We have developed a critical care model of pediatric closed head
injury that utilizes a large animal model to enable full clinical
modalities used in neurointensive care, as well as a recently em-
ployed clinically relevant anesthetic plan to improve the transla-
tional potential.10,11 We have previously reported that early CPP
support to 70mm Hg with PE resulted in a greater reduction in
metabolic crisis and cell injury volumes than targeting a CPP of
40mm Hg.12 The goal of this study was to compare the efficacy of
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PE with NE to target a CPP of 70mm Hg early after nonimpact
inertial brain injury. To determine differences in the injured brain’s
response to PE and NE, we measured cerebrovascular physiology
including CBF, brain tissue oxygen tension, and cellular metabo-
lism (via microdialysis) and assessed short-term neuropathology.
Methods
Animal preparation
All procedures were approved by the Institutional Animal Care
and Use Committee of the University of Pennsylvania. Female,
4-week-old piglets (8–10 kg), were pre-medicated with intramus-
cular injection of ketamine (20mg/kg) and xylazine (2mg/kg)
followed by 4% isoflurane and 100% FiO2 via snout mask, until
abolishment of a reflexive withdrawal to a pinch stimulus. En-
dotracheal intubationwas followed by a decrease in FiO2 to 21–30%,
and maintenance anesthesia was provided using 2% isoflurane. Fe-
moral artery and venous catheters were placed for continuous MAP
monitoring, arterial blood gas sampling, and intravenous (IV) fluid
administration. Vital signs, including heart rate, respiratory rate,
MAP zeroed to the right atrium, arterial oxygen saturation (SaO2),
end tidal CO2, and rectal temperature, were recorded every 10min
for the duration of the experiment. A 20mL/kg normal saline (NS)
bolus was administered for replacement of pre-anesthetic dehydra-
tion secondary to required fasting, followed by an NS infusion at
4mL/kg/h. Mechanical ventilation was titrated with goals of nor-
moxia (PaO2 > 90mmHg) and normocarbia (PaCO2 38–45mmHg).
A core body temperature goal of 37–38.5C to ensure accurate
thermal diffusion CBF measurements was accomplished with con-
ductive warming/cooling blanket system (Gaymar, Orchard Park,
NY). Piglets were then given a bolus of 1mg/kg midazolam and
50lg/kg fentanyl and started on midazolam and fentanyl infusions
(1mg/kg/h and 100lg/kg/h, respectively), and isoflurane was dis-
continued. Pre- and post-injury arterial blood gas samples were ob-
tained hourly (Nova Biomedical,Waltham, MA) until euthanasia 6 h
after injury.
Nonimpact rotational brain injury
Animals (n= 16) experienced rapid sagittal head rotations
without impact (angle rotation 90 degrees over 10–12msec) as
described previously.13–15 Angular velocity was measured using an
angular rate sensor (ATA, Albuquerque, NM) attached to the
linkage sidearm. After injury, the animal was removed from the bite
plate and placed in the prone position.
Neuromonitoring
After injury, four burr holes were prepared for placement of
fiberoptic intracranial pressure monitor, CBF thermal diffusion
probe, brain tissue oxygen monitor, and microdialysis probe. The
fiberoptic intracranial pressure probe (Integra, Plainsboro, NJ), was
inserted 0.5 cm posterior to the coronal suture and 0.5 cm to the left
of the sagittal suture and secured with a single lumen bolt. The
Licox catheter system (Integra, Plainsboro, NJ) was placed to
measure brain tissue oxygenation (PbtO2) 1 cm anterior to the in-
tracranial pressure probe. The brain tissue oxygen probe was in-
serted to a depth of 1.5 cm, secured with bone wax, and allowed to
equilibrate for 30min before values were recorded. A hyperoxia
test was performed to confirm proper catheter placement. Data for
intracranial pressure and PbtO2 were recorded every 15min until
euthanasia.
A microdialysis probe (PAS 12, 4mm length, CMA, North
Chelmsford, MA) was placed on the opposite side of the skull from
the PbtO2 catheter into subcortical white matter. Immediately after
insertion, the probe was infused with sterile 0.9% NaCl at a rate of
1 lL/min. Dialysate samples were collected every 30min until
euthanasia, and stored at - 80C and analyzed for lactate and py-
ruvate using a CMA600 analyzer (CMA, North Chelmsford, MA).
CBF of the right frontal lobe subcortical white matter was
measured continuously with a thermal diffusion intraparenchymal
probe (Hemedex, Cambridge, MA) inserted 1 cm anterior to the
microdialysis probe.16,17
Cerebral perfusion modulation
One hour after injury, animals were randomized to receive either
PE (n = 8) or NE (n= 8) infusions titrated to a CPP > 70mm Hg for
5 h until euthanasia.
Histology
At 6 hours post-injury, animals were euthanized via an overdose
of pentobarbital. Brains were perfusion fixed, and two 6 lm sec-
tions were cut from every 3mm block. Sections were stained with
Hematoxylin and Eosin (H&E), or with the immunohistochemical
marker for axonal injury beta-amyloid precursor protein (b-APP)
(Chemicron 22C11 used at dilution of 1:5000) and counterstained
with Meyer’s hematoxylin. Areas of cell injury on H&E staining
were identified by changes in staining intensity, and characterized
by cell shrinkage and cytoplasmic eosinophilia, so-called ‘‘red cell
change.’’18 Regions of b -APP immunoreactivity and cell injury
were noted by a blinded neuropathologist. and the locations of
white matter damage and cell injury were traced in each slice using
our previously described procedure to determine total area.10 Total
and injured areas were multiplied by section thickness to determine
total and injured brain volumes.
Table 1. Injury, Weight, and Vasopressor Dose Table
Parameter Phenylephrine Norepinephrine
Weight (kg) 8.4 – 1.4 8.6 – 0.8
Velocity (rad/sec) 142 – 3.1 142.2– 1.7
Acceleration (rad/sec2) 62,603– 10,369 55,911– 6,919
Maximum vasopressor dosage
(lg/kg/min)
7.9 – 5.2 0.9 – 0.7




Baseline 117 – 17 122 – 14
1 h 92– 14 102 – 26
3 h 66– 14 147 – 55*
6 h 81– 25 127 – 16*
MAP (mm Hg)
Baseline 70– 9 76 – 7
1 h 73– 10 71 – 5
3 h 87– 5 86 – 12
6 h 90– 9 88 – 15
Temperature (C)
Baseline 36.4 – 0.2 36.5 – 0.5
1 h 36.5 – 0.5 36.6 – 0.6
3 h 36.9 – 0.4 37.3 – 0.6
6 h 37.2 – 0.5 37.5 – 0.5
*Denotes statistically significant difference, p < 0.05 with Tukey–
Kramer post-hoc analysis,– standard deviation.
MAP, mean arterial pressure.
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Statistical analysis
Physiological, arterial blood gas, and neuromonitoring pa-
rameter (intracranial pressure [ICP], PbtO2, microdialysis, CBF)
data were analyzed across groups and time using repeated
measures ANOVA tests, and Tukey–Kramer tests were used for
post-hoc analysis with significance defined as p < 0.05. Neuro-
pathology comparisons between groups were analyzed using
Student’s t test.
Results
Injury and physiological data
Angular peak velocity and acceleration were similar between the
two groups (Table 1). Physiological and arterial blood gas data for
NE and PE are shown in Table 2 and Table 3 respectively. Heart
rate was significantly higher in the NE group after vasopressor ini-
tiation for CPP modulation. Higher blood glucose and lactate levels
5 h after initiation of vasopressor support occurred in animals re-
ceiving NE (Table 3). It is of note that we observed a baseline
metabolic alkalosis in all animals consistent with previous reports.19
Intracranial monitoring
After initiation of CPP modulation with NE or PE infusion, there
was no statistically significant difference in CPP between the
groups (Fig. 1). ICP was unchanged after the initiation of vaso-
pressor infusions for CPP support (Fig. 1).
In order to assess brain tissue’s response to CPP modulation, we
measured PbtO2, microdialysate lactate pyruvate ratios (LPR), and
CBF. PbtO2 was higher for NE than for PE 2 h after the initiation of
CPP support (Fig. 2). PbtO2 responded to CPP modulation in both
groups, and was significantly higher during the post-injury interval
of 3–6 h compared with initial values measured within 1 h of injury
in both groups.
After initiation of CPP support, PE had significantly lower LPR
than NE ( p < 0.05) (Fig. 3). There was no correlation between
microdialysate and serum lactate levels. Repeated measures
ANOVA analysis of CBF revealed only a significant time effect
(Fig. 4) ( p < 0.05) with CBF increasing in both groups over time.
Neuropathology
Neuropathology revealed regions of injury predominantly in the
frontal and parietal lobes. One animal was excluded from traumatic
axonal injury analysis because of global ischemic injury with
widespread associated ischemic white matter injury, which pre-
vented accurate assessment of traumatic axonal injury. Traumatic
axonal injury volumes at 6 h post- injury as determined by b-APP
immunohistochemistry were not different between the two groups
(Fig. 5). Cell injury volumes determined by H&Ewere significantly
larger in NE than in PE (1.4% vs. 0.4%, p < 0.05). Regions of cell
injury were predominantly observed in cortical regions of the
frontal lobes.
Table 3. Arterial Blood Gas Values
Parameter Phenylephrine Norepinephrine
pH
Baseline 7.54 – 0.04 7.55 – 0.03
1 h 7.54 – 0.04 7.54 – 0.05
3 h 7.54 – 0.04 7.54 – 0.04
6 h 7.55 – 0.03 7.52 – 0.04
PaCO2 (torr)
Baseline 43.5 – 2.0 42.2 – 3.6
1 h 43.7 – 4.9 40.5 – 2.8
3 h 40.5 – 0.5 41.3 – 4.4
6 h 37.8 – 2.5 40.6 – 4.7
PaO2 (torr)
Baseline 115.1– 19.9 119.1– 20.7
1 h 123.6– 15.6 127.9– 11.5
3 h 125.1– 23.1 121.7– 22.1
6 h 115.2– 13.0 123.8– 18.4
Lactate (mmol/L)
Baseline 1.5 – 0.1 1.2 – 0.3
1 h 0.9 – 0.2 0.9 – 0.2
3 h 1.0 – 0.2 1.7 – 0.2
6 h 0.7 – 0.1 1.5 – 0.4*
Sodium (mmol/L)
Baseline 141.2– 2.5 140.8– 2.9
1 h 139.6– 2.3 140.1– 2.1
3 h 138.0– 2.1 140.1– 4.3
6 h 138.1– 1.8 137.8– 2.2
Glucose (mg/dL)
Baseline 73 – 8 75– 10
1 h 130 – 20 126– 22
3 h 131 – 25 175– 31
6 h 88 – 20 175– 28*
Arterial blood gas data pre-injury, 1 h, 3 h, and 6 h post-injury.
*Denotes statistically significant difference, p< 0.05– standard deviation.
FIG. 1. Intracranial pressure (ICP) and cerebral perfusion pressure (CPP) over time. PE, phenylephrine; NE, norepinephrine.
DIFFERING EFFECTS OF VASOPRESSORS TO AUGMENT CBF 239
Discussion
We have previously demonstrated a neuroprotective effect of
early CPP augmentation following TBI with PE to a CPP of 70mm
Hg in a clinically relevant large animal model of pediatric neuro-
critical care.12 However, several other vasopressors are commonly
utilized clinically to augment CPP, and the conclusions in our
previous study were limited by the use of volatile anesthetics during
the post-injury period. In the present study, utilizing an opioid-
benzodiazepine-based anesthetic protocol, we compared early CPP
augmentation with PE or NE, and identified differences in physi-
ologic responses, brain tissue oxygen, cellular metabolism, and
acute neuropathology.
Physiologic effects of utilizing a clinically relevant anes-
thetic protocol. In our previous study, animals were anesthetized
with a combination of inhaled isoflurane and intravenous fentanyl
infusions for the duration of the study. Volatile anesthetics have
well-known effects on cerebral autoregulation and neuroprotection,
and are not typically utilized in the intensive care management of
the child with a severe brain injury, a limitation in our previous
study.20–24 Furthermore, uninjured immature swine anesthetized
with an opioid-benzodiazepine-based anesthetic protocol have a
preserved autoregulation response to vasopressor challenges
compared with animals anesthetized with a volatile anesthetic-
based protocol.11 This is illustrated by the differences in CBF
measured in our current experiments compared with previous
studies that utilized a volatile anesthetic-based protocol.11 CPP
augmentation to 70mm Hg with PE resulted in significantly higher
CBF values in swine receiving a volatile anesthetic-based protocol
than in our current studies (Table 4). The translatability of our
findings to the clinical setting in the intensive care unit (ICU) is
strengthened by the use of an opioid-benzodiazepine-based anes-
thetic protocol.
Differences in physiologic effects of CPP augmentation
with PE and NE. We expected differences in physiologic re-
sponses of the animals to PE and NE infusions based on the
a-agonist-only activity of PE and the a and b-agonist activity of
NE. Not surprisingly, animals receiving PE infusions developed a
relative reflexive bradycardia during CPP augmentation, whereas
animals receiving NE did not. Similar findings were found in a
retrospective cohort of adult TBI patients receiving vasopressor
infusions.6 We did not observe any evidence for systemic tissue
hypoperfusion in either group. Although arterial blood lactate
levels were statistically higher at 6 h post-injury in the NE group
(Table 3), this was not clinically significant. Previous studies in
adults have reported an increase in adult respiratory distress syn-
drome (ARDS) with aggressive CPP support, and pulmonary
edema has been reported in adult swine receiving phenylephrine
infusions for CPP support.25,26 We did not observe any changes in
PaO2 or FiO2 requirements during PE or NE infusions. Nor-
epinephrine is a known an inhibitor of insulin release from pan-
creatic b-cells, whereas phenylephrine has been reported to have
little or no influence on blood glucose levels.27,28 Not surprisingly,
we did observe higher blood glucose levels in animals receiving NE
infusions than in animals receiving PE infusions.
CPP support with PE or NE improves CBF following
nonimpact brain injury. Human studies of direct repeated
measurements of CBF over time during cerebral resuscitation are
FIG. 2. Brain tissue oxygen tension over time. PE, phenylephrine; NE, norepinephrine. *p < 0.05 for drug effect on two way ANOVA
analysis.
FIG. 3. Lactate pyruvate ratio (LPR) over time. PE, phenylephrine. NE, norepinephrine. *p < 0.05.
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limited.29 Our clinically relevant large animal model provides a
unique opportunity to monitor changes in CBF, and, more accu-
rately models early cerebrovascular dynamics in the severely brain-
injured child. Increasing CPP with either PE or NE increased CBF,
with slightly larger increases observed with NE. No increases in
ICP were observed during CPP support during this early post-injury
time interval. It should be noted that CPP support to 70mmHgwith
either vasopressor resulted in CBF reaching levels previously ob-
served in uninjured animals receiving the same anesthetic protocol
(Table 4).11
NE infusions for CPP support improved PbtO2, but wors-
ened brain cellular metabolic crisis. Increases in PbtO2 fol-
lowing initiation of CPP support was observed in both groups, but
animals receiving NE infusions had statistically significantly
higher PbtO2. These differences in PbtO2 can be at least partly
attributed to higher increases in CBF in animals receiving NE in-
fusions. Increases in regional oxygenation and CBF have also been
found in adult severe TBI patients receiving NE to drive CPP to
> 70mm Hg.30 CPP augmentation with NE did not reduce micro-
dialysate LPR similar to findings in adult patients with TBI.30
However, vasopressor support with PE did result in a reduction in
LPR, similar to our previous results.12 Interpretation of these varied
responses to two different vasopressors is complex, but discussion
of the limitations of the multimodal monitoring methods utilized
and the relevant literature provides some insight. There is no clear
consensus on the physiological interpretation of PbtO2.
31 Most
likely, PbtO2 reflects the accumulation of oxygen in the brain ex-
tracellular space, which is directly influenced by three factors:
oxygen delivery, oxygen diffusion characteristics of the region of
interest, and oxygen utilization by the brain tissue. If we assume
that infusions of PE and NE have similar effects on diffusion
characteristics of the region of interest, differences in PbtO2 can be
attributed to oxygen delivery and/or oxygen utilization. Animals
receiving NE had higher CBF, although not statistically significant
compared with PE. With regard to oxygen utilization, brain mito-
chondrial dysfunction has been previously reported in swine un-
dergoing nonimpact inertial brain injury.32 Furthermore, in vitro
exposure of neurons to NE, epinephrine, or dopamine resulted in
induction of mitochondrial dysfunction and exacerbation of oxi-
dative stress.33 Despite similar CBF between NE and PE, we
speculate that reductions in mitochondrial function with NEmay be
responsible for less oxygen utilization (higher PbtO2) and more
hypoxic-ischemic injury (Fig. 5) than PE. Similar studies with
a-only agonists such as PE have not been published, to our knowl-
edge. Further investigation is warranted on the effects of various
vasopressors on brain mitochondrial dysfunction following TBI.
Early CPP augmentation with PE results in greater re-
duction in cell injurythan with NE. In our model, we evaluated
the efficacy of CPP support with PE compared with NE before
severe intracranial hypertension. At 6 h post-injury, there were no
differences in the amount of axonal injury detected by b-APP im-
munohistochemistry, similar to our previous investigations. CPP
FIG. 4. Cerebral blood flow over time measured via thermal diffusion. PE, phenylephrine; NE, norepinephrine.
FIG. 5. Traumatic axonal injury volumes determined by beta-
amyloid precursor protein (b-APP) immunohistochemistry and
cell injury volumes determined by hematoxylin and eosin (H&E)
at 6 h post-injury. PE, phenylephrine; NE, norepinephrine.
*p < 0.05.






Sham 35– 10 71 – 11
Sham with isoflurane 60– 9 54 – 2
Injury+ norepinephrine 37– 12 71 – 7
Injury+ phenylephrine 32– 10 73 – 7
Injury+ phenylephrine
with isoflurane
53– 8 71 – 4
Sham with isoflurane and Injury+ phenylephrine with isoflurane previ-
ously published data. 11,19
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support early after TBI may not alter axonal injury, or the early time
point for evaluation may preclude detecting differences between
the groups.34,35 Both groups demonstrated a reduction in cell injury
compared with previous investigations with no CPP support, or
only to a level of 40mm Hg. However, animals receiving PE had
less cell injury than those receiving NE. One possible explanation is
the proposed differences in the vasopressors’ effect on mitochon-
drial dysfunction, as described.
Limitations
There are several limitations to our experimental design, which
must be considered when attempting to translate our findings to the
ICU. First, our model of nonimpact inertial brain injury does not
encompass the full range of the pathophysiology of pediatric TBI.
Specifically, the pathophysiologic responses of pericontusional
tissue may differ from what we observed in our diffuse brain injury
model. The newly funded comparative effectiveness trial in pedi-
atric TBI will, we hope, provide further insight into the efficacy of
various vasopressors for CPP support.36 Second, our time point for
histological examination was relatively acute, and differences in
the response of white matter injury to the effects of our intervention
may not be apparent at such an earlier post-injury time point.34,35
Third, animals in our study did not achieve severe intracranial
hypertension, because of the short post-injury interval. It is unclear
if cerebrovascular responses to NE and PE would change in the
presence of severe intracranial hypertension. Finally, we only uti-
lized female swine in our studies, and sex-dependent differences in
the cerebrovascular responses to various vasopressors in swine
following TBI have been reported.37–39
Conclusion
Utilizing a clinically relevant opioid-benzodiazepine-based an-
esthetic protocol, early CPP support following TBI with NE or PE
resulted in differences in brain tissue oxygen, cellular metabolism,
and acute neuropathology. Early CPP augmentation after TBI with
NE resulted in greater increase in brain tissue oxygen tension than
augmentation with PE, despite similar increases in CBF. However,
animals receiving PE were found to have greater reduction in met-
abolic crisis and cell injury. Future clinical studies comparing the
effectiveness of various vasopressors for CPP support are warranted.
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